tradingkey.logo
tradingkey.logo

IDEXX Laboratories Inc

IDXX
688.480USD
+0.300+0.04%
終値 12/26, 16:00ET15分遅れの株価
55.08B時価総額
54.18直近12ヶ月PER

IDEXX Laboratories Inc

688.480
+0.300+0.04%

詳細情報 IDEXX Laboratories Inc 企業名

IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services primarily for the companion animal veterinary, livestock and poultry, dairy and water testing industries. The Company also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. The LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, and to improve the quality and safety of milk.

IDEXX Laboratories Incの企業情報

企業コードIDXX
会社名IDEXX Laboratories Inc
上場日Jun 21, 1991
最高経営責任者「CEO」Emerson (Andrew)
従業員数11000
証券種類Ordinary Share
決算期末Jun 21
本社所在地One Idexx Drive
都市WESTBROOK
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号04092-2041
電話番号12075560300
ウェブサイトhttps://www.idexx.com/
企業コードIDXX
上場日Jun 21, 1991
最高経営責任者「CEO」Emerson (Andrew)

IDEXX Laboratories Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Michael Erickson, Ph.D.
Mr. Michael Erickson, Ph.D.
Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine
Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine
12.58K
+18.05%
Dr. Sophie V. Vandebroek, Ph.D.
Dr. Sophie V. Vandebroek, Ph.D.
Independent Director
Independent Director
8.69K
+3.11%
Mr. Lawrence D. (Larry) Kingsley
Mr. Lawrence D. (Larry) Kingsley
Independent Chairman of the Board
Independent Chairman of the Board
8.23K
+4.39%
Mr. Michael J. Lane
Mr. Michael J. Lane
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology
7.70K
--
Ms. Sharon E. Underberg
Ms. Sharon E. Underberg
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
6.12K
+3.08%
Mr. Andrew Emerson
Mr. Andrew Emerson
Executive Vice President, Chief Executive Officer, Treasurer
Executive Vice President, Chief Executive Officer, Treasurer
3.84K
+60.39%
Mr. Daniel M. (Dan) Junius
Mr. Daniel M. (Dan) Junius
Independent Director
Independent Director
3.00K
+9.56%
Mr. Michael Schreck
Mr. Michael Schreck
Executive Vice President and General Manager, Veterinary Software and Services, Corporate Accounts and Customer Experience
Executive Vice President and General Manager, Veterinary Software and Services, Corporate Accounts and Customer Experience
1.92K
+112.86%
Mr. Bruce L. Claflin
Mr. Bruce L. Claflin
Independent Director
Independent Director
1.72K
--
Dr. Stuart M. Essig, Ph.D.
Dr. Stuart M. Essig, Ph.D.
Independent Director
Independent Director
1.09K
+31.76%
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Michael Erickson, Ph.D.
Mr. Michael Erickson, Ph.D.
Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine
Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine
12.58K
+18.05%
Dr. Sophie V. Vandebroek, Ph.D.
Dr. Sophie V. Vandebroek, Ph.D.
Independent Director
Independent Director
8.69K
+3.11%
Mr. Lawrence D. (Larry) Kingsley
Mr. Lawrence D. (Larry) Kingsley
Independent Chairman of the Board
Independent Chairman of the Board
8.23K
+4.39%
Mr. Michael J. Lane
Mr. Michael J. Lane
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology
7.70K
--
Ms. Sharon E. Underberg
Ms. Sharon E. Underberg
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
6.12K
+3.08%
Mr. Andrew Emerson
Mr. Andrew Emerson
Executive Vice President, Chief Executive Officer, Treasurer
Executive Vice President, Chief Executive Officer, Treasurer
3.84K
+60.39%

収益内訳

通貨: USD更新時刻: Mon, Oct 6
通貨: USD更新時刻: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
事業別USD
会社名
収益
比率
CAG Diagnostics recurring revenue
878.00M
79.14%
IDEXX VetLab consumables
375.11M
33.81%
Reference laboratory diagnostic and consulting services
367.69M
33.14%
Rapid assay products
100.24M
9.04%
CAG Diagnostics capital - instruments
85.85M
7.74%
他の
-697.43M
-62.86%
地域別USD
会社名
収益
比率
United States
717.87M
64.70%
Europe & Middle East & Africa (EMEA) (Region)
233.27M
21.03%
Asia Pacific
89.30M
8.05%
Canada
46.69M
4.21%
Latin America
22.33M
2.01%
事業別
地域別
事業別USD
会社名
収益
比率
CAG Diagnostics recurring revenue
878.00M
79.14%
IDEXX VetLab consumables
375.11M
33.81%
Reference laboratory diagnostic and consulting services
367.69M
33.14%
Rapid assay products
100.24M
9.04%
CAG Diagnostics capital - instruments
85.85M
7.74%
他の
-697.43M
-62.86%

株主

更新時刻: Sun, Nov 16
更新時刻: Sun, Nov 16
株主統計
種類
株主統計
株主統計
比率
The Vanguard Group, Inc.
12.43%
BlackRock Institutional Trust Company, N.A.
6.56%
State Street Investment Management (US)
4.41%
Fundsmith LLP
3.27%
Geode Capital Management, L.L.C.
3.13%
他の
70.21%
株主統計
株主統計
比率
The Vanguard Group, Inc.
12.43%
BlackRock Institutional Trust Company, N.A.
6.56%
State Street Investment Management (US)
4.41%
Fundsmith LLP
3.27%
Geode Capital Management, L.L.C.
3.13%
他の
70.21%
種類
株主統計
比率
Investment Advisor
53.74%
Investment Advisor/Hedge Fund
30.98%
Research Firm
3.98%
Pension Fund
2.91%
Bank and Trust
1.86%
Individual Investor
0.69%
Sovereign Wealth Fund
0.59%
Hedge Fund
0.54%
Family Office
0.50%
他の
4.22%

機関投資家保有株

更新時刻: Wed, Oct 1
更新時刻: Wed, Oct 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q3
2319
77.76M
97.19%
-4.03M
2025Q2
2277
79.81M
99.73%
-1.01M
2025Q1
2279
79.02M
98.21%
-512.23K
2024Q4
2242
76.14M
93.59%
-5.30M
2024Q3
2152
77.90M
94.66%
-4.67M
2024Q2
2140
80.09M
96.98%
-924.14K
2024Q1
2154
77.56M
93.40%
-2.57M
2023Q4
2187
77.94M
93.84%
-2.83M
2023Q3
2153
79.23M
95.34%
-677.16K
2023Q2
2157
77.53M
93.40%
-1.56M
詳細を見る

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
The Vanguard Group, Inc.
9.84M
12.3%
+19.20K
+0.20%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
5.30M
6.63%
-132.86K
-2.44%
Jun 30, 2025
State Street Investment Management (US)
3.55M
4.44%
-95.45K
-2.62%
Jun 30, 2025
Fundsmith LLP
2.64M
3.3%
-9.04K
-0.34%
Jun 30, 2025
Geode Capital Management, L.L.C.
2.46M
3.08%
+54.40K
+2.26%
Jun 30, 2025
Baron Capital Management, Inc.
2.03M
2.54%
-27.16K
-1.32%
Jun 30, 2025
Invesco Capital Management (QQQ Trust)
1.65M
2.06%
-5.80K
-0.35%
Aug 31, 2025
Principal Global Investors (Equity)
1.13M
1.41%
+1.75K
+0.16%
Jun 30, 2025
Polen Capital Management, LLC
1.20M
1.49%
+1.12M
+1519.07%
Jun 30, 2025
Walter Scott & Partners Ltd.
756.69K
0.95%
+597.11K
+374.18%
Jun 30, 2025
詳細を見る

関連ETF

更新時刻: Tue, Dec 2
更新時刻: Tue, Dec 2
銘柄名
比率
ProShares Pet Care ETF
9.4%
iShares U.S. Medical Devices ETF
4.42%
First Trust Water ETF
3.98%
SMI 3Fourteen Full-Cycle Trend ETF
3.9%
Nuveen ESG Mid-Cap Growth ETF
3.47%
Adaptive Core ETF
2.61%
First Trust S&P 500 Economic Moat Index ETF
2.25%
Acruence Active Hedge US Equity ETF
2.18%
Tema Durable Quality ETF
2.1%
Putnam Sustainable Future ETF
2.03%
詳細を見る
ProShares Pet Care ETF
比率9.4%
iShares U.S. Medical Devices ETF
比率4.42%
First Trust Water ETF
比率3.98%
SMI 3Fourteen Full-Cycle Trend ETF
比率3.9%
Nuveen ESG Mid-Cap Growth ETF
比率3.47%
Adaptive Core ETF
比率2.61%
First Trust S&P 500 Economic Moat Index ETF
比率2.25%
Acruence Active Hedge US Equity ETF
比率2.18%
Tema Durable Quality ETF
比率2.1%
Putnam Sustainable Future ETF
比率2.03%

配当金

過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし

株式分割

日付
種類
比率
データなし
日付
種類
比率
データなし

よくある質問

IDEXX Laboratories Incの上位5名の株主は誰ですか?

IDEXX Laboratories Incの上位5名の株主は以下のとおりです。
The Vanguard Group, Inc.は9.84M株を保有しており、これは全体の12.30%に相当します。
BlackRock Institutional Trust Company, N.A.は5.30M株を保有しており、これは全体の6.63%に相当します。
State Street Investment Management (US)は3.55M株を保有しており、これは全体の4.44%に相当します。
Fundsmith LLPは2.64M株を保有しており、これは全体の3.30%に相当します。
Geode Capital Management, L.L.C.は2.46M株を保有しており、これは全体の3.08%に相当します。

IDEXX Laboratories Incの株主タイプ上位3種は何ですか?

IDEXX Laboratories Incの株主タイプ上位3種は、
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)

IDEXX Laboratories Inc(IDXX)の株式を保有している機関の数はいくつですか?

2025Q3時点で、IDEXX Laboratories Incの株式を保有している機関は2319社あり、保有株式の総市場価値は約77.76Mで、全体の97.19%を占めています。2025Q2と比較して、機関の持ち株は-2.54%増加しています。

IDEXX Laboratories Incの最大の収益源は何ですか?

FY2025Q2において、CAG Diagnostics recurring revenue部門がIDEXX Laboratories Incにとって最大の収益を生み出しており、その金額は878.00Mで、全収益の79.14%を占めています。
KeyAI